
The presence of N-nitrosamine impurities in pharmaceutical products, even at ultra-trace levels, has emerged as a major regulatory and public health concern because of their carcinogenic risk. In this study, a robust, ultrasensitive, and environmentally sustainable LC–MS/MS method was developed and validated for the simultaneous determination of three critical nitrosamine impurities: N-nitrosodimethylamine (NDMA), N-nitrosodiethylamine (NDEA), and N-nitroso-N-methyl-4-aminobutyric acid (NMBA). The method was successfully applied to determine of these nitrosamines in pharmaceutical formulations containing albendazole, sotalol HCl, and nalbuphine HCl. Chromatographic separation was achieved using Eclipse Plus C8 (4.6 × 250 mm) and Kinetex® F5 (4.6 × 100 mm) columns with gradient elution using 0.1% formic acid in water and methanol. The proposed method provided efficient separation within 9 min at a flow rate of 0.6 mL/min and a column temperature of 40 °C. Validation was performed according to ICH guidelines, demonstrating excellent linearity (r > 0.99), good precision, accuracy, selectivity, and specificity. The validated linearity ranges were 1–25 ng/mL for albendazole, 0.25–100 ng/mL for sotalol HCl and nalbuphine HCl, with limits of quantification as low as 1 ng/mL. Recoveries ranged from 70.9% to 116.1%. In silico ADMET analysis indicated potential hepatotoxicity risks for all investigated nitrosamines, emphasizing the importance of continuous monitoring. Furthermore, the method demonstrated strong green analytical performance, with BAGI scores of 75.0–77.5 and AGREE values of 0.58–0.60. The developed LC–MS/MS method offers a sensitive, reliable, and environmentally sustainable approach for routine monitoring of nitrosamine impurities in pharmaceutical formulations for quality control purposes. Validated sensitive LC–MS/MS method for simultaneous determination of NDMA, NDEA, and NMBA in pharmaceutical formulations.Fast, accurate, and highly selective analysis with ng/mL sensitivity suitable for regulatory quality control.Integrated green analytical chemistry assessment with in silico ADMET profiling for comprehensive evaluation of nitrosamine impurities. Validated sensitive LC–MS/MS method for simultaneous determination of NDMA, NDEA, and NMBA in pharmaceutical formulations. Fast, accurate, and highly selective analysis with ng/mL sensitivity suitable for regulatory quality control. Integrated green analytical chemistry assessment with in silico ADMET profiling for comprehensive evaluation of nitrosamine impurities.
This study describes the development and validation of a liquid chromatography- tandem mass spectrometry (LC-MS/MS) method for quantification of N-Nitroso diclofenac in diclofenac sodium drug substance and tablet dosage forms. Chromatographic separation was achieved on a Phenomenex Kinetex C18 column using gradient elution with 5 mM ammonium formate in water containing 0.1% formic acid and methanol at a flow rate of 0.5 mL/min. Detection was carried out in positive electrospray ionization mode using multiple reaction monitoring (MRM) transitions at m/z 294.95 -> 241.98 (quantifier) and m/z 294.95 -> 213.98 (qualifier). To facilitate selective trace-level quantification, the analytical strategy incorporated in-source fragmentation of the labile N-NO bond generating a chemically stable denitrosated precursor ion at m/z 294.95 (loss of NO, 30 Da). The method demonstrated excellent sensitivity with limits of detection and quantification of 0.125 ng/mL and 0.250 ng/mL, respectively. The calibration curve was linear over the concentration range of 0.249-3.735 ng/mL with a correlation coefficient of 0.99997. The validated LC-MS/MS method is suitable for routine quality control and trace-level determination of N-Nitroso diclofenac in pharmaceutical matrices.
The chromatographic separation of polar and ionic compounds remains a persistent challenge in analytical science. Conventional reversed-phase liquid chromatography (RP-LC) often fails to retain such analytes adequately, resulting in poor peak shapes, tailing, and compromised resolution, which limit reliable qualitative and quantitative analysis in pharmaceutical, biological, and environmental samples. This review critically evaluates ion-pair chromatography (IPC) as a versatile analytical strategy to enhance retention, selectivity, and separation efficiency for polar and ionic analytes across diverse application domains. A literature survey was performed using major databases, including Google Scholar, PubMed, Scopus, and Web of Science, focusing on IPC principles, ion-pair reagents, key chromatographic parameters, method development, and recent advances, with emphasis on MS-compatible and green analytical approaches. We found that, the ion-pair chromatography (IPC) enhances separation on reversed-phase columns via ion-pair formation, dynamic ion exchange, and partitioning. It is widely applied in pharmaceutical analysis, bioanalysis, and environmental/food monitoring. Recent advances such as volatile ion-pair reagents, mixed-mode columns, and IPC-MS workflows have improved sensitivity, reproducibility, and MS compatibility. We concluded that, ion-pair chromatography remains a powerful and complementary tool for the separation of polar and ionic analytes, with ongoing innovations ensuring enhanced performance, sustainability, and applicability across pharmaceutical, biological, and environmental matrices.
A sensitive and reliable LC-MS/MS method was developed and validated for the quantification of N-Nitroso-Norcodeine in Codeine Phosphate. N-Nitroso-Norcodeine is a structurally related nitrosamine drug substance-related impurity that may form in codeine phosphate by nitrosation of the opioid amine functionality. Owing to the potential mutagenic and carcinogenic liability of nitrosamine impurities, sensitive sub-ppm analytical control is required to support regulatory compliance and patient safety. This study describes the development and validation of a LC-MS/MS method for trace quantification of N-Nitroso-Norcodeine in codeine phosphate drug substance. Detection was performed in multiple reaction monitoring mode using positive electrospray ionization. The method was linear over the calibration range 0.104-1.559 ng/mL. The limits of detection and quantification were 0.052 ng/mL, and 0.104 ng/mL, corresponding to 0.41 ppm relative to codeine phosphate and meeting the regulatory target derived from the 1500 ng/day acceptable intake limit. Recovery ranged from 94.5% to 105.9%, with percentage relative standard deviation values <= 1.0%, and robustness was demonstrated under deliberate chromatographic and mass spectrometric variations. The fragmentation behavior of N-Nitroso-Norcodeine was interpreted using established morphinan collision-induced-dissociation (CID) pathways. Overall, the validated method provides a sensitive, selective, and regulatory-aligned platform for routine monitoring of N-Nitroso-Norcodeine in codeine phosphate drug substance.